Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours Meeting Abstract


Authors: Ziegler, D. S.; Doz, F.; Geoerger, B.; Dubois, S.; Grilley-Olson, J. E.; van Tilburg, C.; Italiano, A.; Lissat, A.; Kang, J. H.; Tahara, M.; Boni, V.; Perreault, S.; Capra, M.; Nanda, S.; Brega, N.; Holynskyj, A.; Hong, D. S.; Hyman, D.; Drilon, A.
Abstract Title: Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours
Meeting Title: 2019 ESMO Asia Congress
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 9
Meeting Dates: 2019 Nov 22-24
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-11-01
Start Page: mdz431.003
Language: English
ACCESSION: WOS:000503487700354
PROVIDER: wos
DOI: 10.1093/annonc/mdz431.003
Notes: Meeting Abstract: 366P -- Appears on page ix124 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Hyman
    354 Hyman
  2. Alexander Edward Drilon
    632 Drilon